(Q42998889)

English

Electroporation enhances immune responses and protection induced by a bovine viral diarrhea virus DNA vaccine in newborn calves with maternal antibodies

scientific article published on July 27, 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Electroporation enhances immune responses and protection induced by a bovine viral diarrhea virus DNA vaccine in newborn calves with maternal antibodies (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

maternal health

0 references

0 references

0 references

electroporation

1 reference

based on heuristic

inferred from title

maternally-acquired immunity

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670907

13 June 2024

Sylvia van Drunen Littel-van den Hurk

1

object named as

Sylvia van Drunen Littel-van den Hurk

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Zoe Lawman

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Don Wilson

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Alain Luxembourg

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Barry Ellefsen

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Drew Hannaman

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Jan V. van den Hurk

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670907

13 June 2024

language of work or name

0 references

publication date

27 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0264410X10010406?httpAccept=text/xml

1 reference

10.1016/J.VACCINE.2010.07.045

https://api.crossref.org/works/10.1016/J.VACCINE.2010.07.045

13 June 2024

https://api.elsevier.com/content/article/PII:S0264410X10010406?httpAccept=text/plain

1 reference

10.1016/J.VACCINE.2010.07.045

https://api.crossref.org/works/10.1016/J.VACCINE.2010.07.045

13 June 2024

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

6445-6454

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Bovine viral diarrhea virus: global status.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Evolution of bovine viral diarrhea virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Segregation of bovine viral diarrhea virus into genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Phylogenetic, antigenic and clinical characterization of type 2 BVDV from North America

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Diversity among bovine pestiviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Distribution of bovine virus diarrhoea virus in tissues and white blood cells of cattle during acute infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Pestiviruses: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Descriptive epidemiology of postnatal bovine viral diarrhea virus infection in intensively managed dairy heifers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Calves born after embryo transfer from donors persistently infected with BVD virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Prevalence of cattle persistently infected with bovine viral diarrhea virus in 20 dairy herds in two counties in central Michigan and comparison of prevalence of antibody-positive cattle among herds with different infection and vaccination status

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Bovine viral diarrhea virus genomic organization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

The amino-terminal domain of bovine viral diarrhea virus Npro protein is necessary for alpha/beta interferon antagonism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Immunogens of bovine viral diarrhea virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Strategies for the control and prevention of bovine viral diarrhea virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Effect of maternal antibodies on induction and persistence of vaccine-induced immune responses against bovine viral diarrhea virus type II in young calves

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Maternal antibody blocks humoral but not T cell responses to BVDV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Induction of T lymphocytes specific for bovine viral diarrhea virus in calves with maternal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Immunization with DNA vaccines in early life: advantages and limitations as compared to conventional vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Immunization of neonates with DNA encoding a bovine herpesvirus glycoprotein is effective in the presence of maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Fetal immunization by a DNA vaccine delivered into the oral cavity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Electroporation-based DNA immunisation: translation to the clinic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Electroporation improves the efficacy of DNA vaccines in large animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Enhancement of DNA vaccine potency in rhesus macaques by electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

In vivo electroporation improves immune responses to DNA vaccination in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Potentiation of an anthrax DNA vaccine with electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Electroporation-based DNA transfer enhances gene expression and immune responses to DNA vaccines in cattle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Codon usage tabulated from international DNA sequence databases: status for the year 2000

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

BVDV genotypes and biotypes: practical implications for diagnosis and control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Practical significance of heterogeneity among BVDV strains: impact of biotype and genotype on U.S. control programs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Bordetella pertussis Infection in 2-Month-Old Infants Promotes Type 1 T Cell Responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Evaluation of protection against virulent bovine viral diarrhea virus type 2 in calves that had maternal antibodies and were vaccinated with a modified-live vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

Proteins encoded by bovine viral diarrhea virus: the genomic organization of a pestivirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

based on heuristic

inferred from DOI database lookup

Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.045

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of bovine viral diarrhea virus on the percentages and absolute numbers of circulating B and T lymphocytes in cattle

8

1 reference

10.1016/J.VACCINE.2010.07.045

https://api.crossref.org/works/10.1016/J.VACCINE.2010.07.045

13 June 2024

Age distribution of animals persistently infected with bovine virus diarrhea virus in twenty-two Danish dairy herds

12

1 reference

10.1016/J.VACCINE.2010.07.045

https://api.crossref.org/works/10.1016/J.VACCINE.2010.07.045

13 June 2024

Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques

57

1 reference

10.1016/J.VACCINE.2010.07.045

https://api.crossref.org/works/10.1016/J.VACCINE.2010.07.045

13 June 2024

Identifiers

10.1016/J.VACCINE.2010.07.045

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42998889&oldid=2178221798"